Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ruijtenbeek

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|February 10, 2012
Serine-305 phosphorylation modulates estrogen receptor alpha binding to a coregulator peptide array, with potential application in predicting responses to tamoxifenRené Houtman, Renée de Leeuw, Mariska Rondaij, et al.
Cancers|September 28, 2023
Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E TargetingRiet Hilhorst, Adrienne van den Berg, Piet Boender, et al.
Current Drug Targets|November 11, 2014
Modulation of signaling enhances the efficacy of the combination of satraplatin and erlotinibAbolfazl Avan, Auke D Adema, Eveline K Hoebe, et al.
Chembiochem : a European Journal of Chemical Biology|July 21, 2009
Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarraysAlex J Poot, Jeroen van Ameijde, Monique Slijper, et al.
Chembiochem : a European Journal of Chemical Biology|March 29, 2002
Replacement of the intervening amino acid sequence of a Syk-binding diphosphopeptide by a nonpeptide spacer with preservation of high affinityFrank J Dekker, Nico J de Mol, Jeroen van Ameijde, et al.
Organic & Biomolecular Chemistry|March 19, 2010
Preparation of novel alkylated arginine derivatives suitable for click-cycloaddition chemistry and their incorporation into pseudosubstrate- and bisubstrate-based kinase inhibitorsJeroen van Ameijde, Alex J Poot, Loek T M van Wandelen, et al.
Chembiochem : a European Journal of Chemical Biology|July 31, 2010
Rapid screening of lectins for multivalency effects with a glycodendrimer microarrayNúria Parera Pera, Hilbert M Branderhorst, Raymond Kooij, et al.
Oncotarget|October 23, 2018
Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profilesTakeshi Sawada, Riet Hilhorst, Savithri Rangarajan, et al.
Biochemical Pharmacology|May 13, 2019
Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell lineNele Van Der Steen, Alessandro Leonetti, Kaylee Keller, et al.
Clinical & Experimental Metastasis|March 19, 2009
Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profilingAse Bratland, Piet J Boender, Hanne K Høifødt, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|February 10, 2012
Serine-305 phosphorylation modulates estrogen receptor alpha binding to a coregulator peptide array, with potential application in predicting responses to tamoxifenRené Houtman, Renée de Leeuw, Mariska Rondaij, et al.
Cancers|September 28, 2023
Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E TargetingRiet Hilhorst, Adrienne van den Berg, Piet Boender, et al.
Current Drug Targets|November 11, 2014
Modulation of signaling enhances the efficacy of the combination of satraplatin and erlotinibAbolfazl Avan, Auke D Adema, Eveline K Hoebe, et al.
Chembiochem : a European Journal of Chemical Biology|July 21, 2009
Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarraysAlex J Poot, Jeroen van Ameijde, Monique Slijper, et al.
Chembiochem : a European Journal of Chemical Biology|March 29, 2002
Replacement of the intervening amino acid sequence of a Syk-binding diphosphopeptide by a nonpeptide spacer with preservation of high affinityFrank J Dekker, Nico J de Mol, Jeroen van Ameijde, et al.
Organic & Biomolecular Chemistry|March 19, 2010
Preparation of novel alkylated arginine derivatives suitable for click-cycloaddition chemistry and their incorporation into pseudosubstrate- and bisubstrate-based kinase inhibitorsJeroen van Ameijde, Alex J Poot, Loek T M van Wandelen, et al.
Chembiochem : a European Journal of Chemical Biology|July 31, 2010
Rapid screening of lectins for multivalency effects with a glycodendrimer microarrayNúria Parera Pera, Hilbert M Branderhorst, Raymond Kooij, et al.
Oncotarget|October 23, 2018
Inactive immune pathways in triple negative breast cancers that showed resistance to neoadjuvant chemotherapy as inferred from kinase activity profilesTakeshi Sawada, Riet Hilhorst, Savithri Rangarajan, et al.
Biochemical Pharmacology|May 13, 2019
Decrease in phospho-PRAS40 plays a role in the synergy between erlotinib and crizotinib in an EGFR and cMET wild-type squamous non-small cell lung cancer cell lineNele Van Der Steen, Alessandro Leonetti, Kaylee Keller, et al.
Clinical & Experimental Metastasis|March 19, 2009
Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profilingAse Bratland, Piet J Boender, Hanne K Høifødt, et al.
Pageof 7